These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2930579)

  • 21. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY; Sciandra J; Siemann DW
    Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of mechanisms of protection against oxidative stress in doxorubicin-resistant rat tumoral cells in culture.
    Benchekroun MN; Catroux P; Montaudon D; Robert J
    Free Radic Res Commun; 1990; 11(1-3):137-44. PubMed ID: 1963616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
    Dusre L; Mimnaugh EG; Myers CE; Sinha BK
    Cancer Res; 1989 Feb; 49(3):511-5. PubMed ID: 2535960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
    Ford JM; Yang JM; Hait WN
    Cancer Res; 1991 Jan; 51(1):67-72. PubMed ID: 1988108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin.
    Larsson R; Bergh J; Nygren P
    Anticancer Res; 1991; 11(1):455-9. PubMed ID: 1850223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.
    Mickisch GH; Roehrich K; Koessig J; Forster S; Tschada RK; Alken PM
    J Urol; 1990 Sep; 144(3):755-9. PubMed ID: 1974934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
    Armstrong DK; Gordon GB; Hilton J; Streeper RT; Colvin OM; Davidson NE
    Cancer Res; 1992 Mar; 52(6):1416-21. PubMed ID: 1540950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes.
    Hao XY; Bergh J; Brodin O; Hellman U; Mannervik B
    Carcinogenesis; 1994 Jun; 15(6):1167-73. PubMed ID: 8020151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
    Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH; Singh SV
    Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclophosphamide resistance in medulloblastoma.
    Friedman HS; Colvin OM; Kaufmann SH; Ludeman SM; Bullock N; Bigner DD; Griffith OW
    Cancer Res; 1992 Oct; 52(19):5373-8. PubMed ID: 1356617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
    Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased levels of alpha-class and pi-class glutathione S-transferases in cell lines resistant to 1-chloro-2,4-dinitrobenzene.
    Wareing CJ; Black SM; Hayes JD; Wolf CR
    Eur J Biochem; 1993 Oct; 217(2):671-6. PubMed ID: 8223610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MDR hamster cells exhibiting multiple altered gene expression: effects of dexniguldipine-HCl (B859-35), cyclosporin A and buthionine sulfoximine.
    Neumann M; Wilisch A; Diddens H; Probst H; Gekeler V
    Anticancer Res; 1992; 12(6B):2297-302. PubMed ID: 1284202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.
    Versantvoort CH; Broxterman HJ; Bagrij T; Scheper RJ; Twentyman PR
    Br J Cancer; 1995 Jul; 72(1):82-9. PubMed ID: 7599070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of melphalan resistance in vivo and in vitro by modulation of glutathione metabolism.
    Medh RD; Gupta V; Awasthi YC
    Biochem Pharmacol; 1991 Jul; 42(2):439-41. PubMed ID: 1859455
    [No Abstract]   [Full Text] [Related]  

  • 37. Methionine and cysteine affect glutathione level, glutathione-related enzyme activities and the expression of glutathione S-transferase isozymes in rat hepatocytes.
    Wang ST; Chen HW; Sheen LY; Lii CK
    J Nutr; 1997 Nov; 127(11):2135-41. PubMed ID: 9372907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of buthionine sulfoximine, an inhibitor of glutathione synthesis, on hepatic drug metabolism in the male mouse.
    White RD; Norton R; Bus JS
    Toxicol Lett; 1984 Oct; 23(1):25-32. PubMed ID: 6485015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of apoptosis is the cause of resistance to doxorubicin in human breast adenocarcinoma cells.
    Osmak M; Brozović A; Ambriović-Ristov A; Hadzija M; Pivcević B; Smital T
    Neoplasma; 1998; 45(4):223-30. PubMed ID: 9890665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells.
    Asakura T; Ohkawa K; Takahashi N; Takada K; Inoue T; Yokoyama S
    Br J Cancer; 1997; 76(10):1333-7. PubMed ID: 9374380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.